BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26068597)

  • 1. Meeting report of the 5th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma.
    Merz M; Hillengass J; Goldschmidt H
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):247-51. PubMed ID: 26068597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meeting report of the 6th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma.
    Merz M; Raab MS; Goldschmidt H; Hillengass J
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2521-2526. PubMed ID: 28653099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meeting report of the 7th Heidelberg Myeloma Workshop: today and tomorrow.
    Baertsch MA; Lutz R; Raab MS; Weinhold N; Goldschmidt H
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2445-2455. PubMed ID: 31407112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of multiple myeloma in Germany: analysis of a nationwide multi-institutional survey.
    Merz M; Kellermann L; Poenisch W; Tischler HJ; Kohnke J; Knauf W; Goldschmidt H
    Ann Hematol; 2017 Jun; 96(6):987-993. PubMed ID: 28409228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New developments in the management and treatment of newly diagnosed and relapsed/refractory multiple myeloma patients.
    van de Donk NW; Lokhorst HM
    Expert Opin Pharmacother; 2013 Aug; 14(12):1569-73. PubMed ID: 23721099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted therapy of multiple myeloma.
    Kyle RA
    Hematology; 2012 Apr; 17 Suppl 1():S125-8. PubMed ID: 22507799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current treatment of refractory and relapsed multiple myeloma].
    Sasaki M
    Rinsho Ketsueki; 2016; 57(10):2084-2095. PubMed ID: 27795518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meeting report of the third Heidelberg myeloma workshop: current status and developments in diagnosis and therapy of multiple myeloma.
    Hillengass J; Neben K; Goldschmidt H
    J Cancer Res Clin Oncol; 2012 Jan; 138(1):173-8. PubMed ID: 21960320
    [No Abstract]   [Full Text] [Related]  

  • 9. Meeting report of the 4th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma.
    Hillengass J; Maximilian M; Goldschmidt H
    J Cancer Res Clin Oncol; 2013 Nov; 139(11):1807-11. PubMed ID: 23864156
    [No Abstract]   [Full Text] [Related]  

  • 10. How is patient care for multiple myeloma advancing?
    Genadieva Stavric S; Bonello F; Bringhen S; Boccadoro M; Larocca A
    Expert Rev Hematol; 2017 Jun; 10(6):551-561. PubMed ID: 28504554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carfilzomib and pomalidomide: recent advances in the treatment of multiple myeloma.
    Highsmith KN; Chen SE; Horowitz S
    Pharmacotherapy; 2014 Sep; 34(9):927-40. PubMed ID: 25044413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Society of Hematology Annual Meeting 2014: highlights in multiple myeloma.
    Glavey SV; Ghobrial IM
    Expert Rev Hematol; 2015 Jun; 8(3):273-5. PubMed ID: 25804827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma: 2013 update on diagnosis, risk-stratification, and management.
    Rajkumar SV
    Am J Hematol; 2013 Mar; 88(3):226-35. PubMed ID: 23440663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging therapies in multiple myeloma.
    El-Amm J; Tabbara IA
    Am J Clin Oncol; 2015 Jun; 38(3):315-21. PubMed ID: 23934133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple myeloma: is a shift toward continuous therapy needed to move forward?
    Guglielmelli T; Palumbo A
    Expert Rev Hematol; 2015 Jun; 8(3):253-6. PubMed ID: 25582032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontline therapy for multiple myeloma: a concise review of the evidence based on randomized clinical trials.
    Yaqub S; Ballester G; Ballester O
    Cancer Invest; 2013 Oct; 31(8):529-37. PubMed ID: 24083815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical roundtable monograph. Emerging treatment options for relapsed and refractory multiple myeloma.
    Siegel DS; Vij R; Jakubowiak AJ
    Clin Adv Hematol Oncol; 2011 Apr; 9(4):1-15. PubMed ID: 21928467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New developments in post-transplant maintenance treatment of multiple myeloma.
    Liu H; McCarthy P
    Semin Oncol; 2013 Oct; 40(5):602-9. PubMed ID: 24135405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of multiple myeloma in the targeted therapy era.
    Saad AA; Sharma M; Higa GM
    Ann Pharmacother; 2009 Feb; 43(2):329-38. PubMed ID: 19193585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple myeloma: diagnosis and treatment.
    Rajkumar SV; Kyle RA
    Mayo Clin Proc; 2005 Oct; 80(10):1371-82. PubMed ID: 16212152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.